Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel El Fassi

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Ugeskrift for Laeger|June 8, 2012
[Treatment of metformin-associated lactate acidosis by haemodialysis]Karin Schousboe, Daniel El Fassi, Erik Lilja Secher, et al.
Clinical Immunology (Orlando, Fla.)|October 31, 2008
Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodiesDaniel El Fassi, J Paul Banga, Jacqueline A Gilbert, et al.
Molecular Diagnosis & Therapy|March 9, 2021
Improved Variant Detection in Clinical Myeloid NGS Testing by Supplementing a Commercial Myeloid NGS Assay with Custom or Extended Data Filtering and Accessory Fragment AnalysisLone Schejbel, Guy Wayne Novotny, Marie Fredslund Breinholt, et al.
Rheumatology (Oxford, England)|December 23, 2023
Treatment experiences with focus on IL-6R inhibition in patients with VEXAS syndrome and a case of remission with azacytidine treatmentMorten M Johansen, Daniel El Fassi, Christoffer T H Nielsen, et al.
Ugeskrift for Laeger|January 5, 2018
[Multicentric reticulohistiocytosis is a rare form of paraneoplasia]Anna Maria Anderson, Tanja Todberg, Kristian Kofoed, et al.
Acta Ophthalmologica|September 30, 2009
Evidence of orbital B and T cell depletion after rituximab therapy in Graves' ophthalmopathyJacob F Nielsen, Daniel El Fassi, Claus H Nielsen, et al.
Ugeskrift for Laeger|February 10, 2023
Rosa Maja Møhring Gynthersen, Frederikke Christina Knudtzen, Anders Porskrog, et al.
International Journal of Laboratory Hematology|February 10, 2022
The value of next-generation sequencing in routine diagnostics and management of patients with cytopeniaMarie Fredslund Breinholt, Kåre Nielsen, Lone Schejbel, et al.
Leukemia & Lymphoma|July 2, 2019
Progression of <i>JAK2-</i>mutant polycythemia vera to <i>CALR</i>-mutant myelofibrosis severely impacts on disease phenotype and response to therapyMorten Orebo Holmström, Guy W Novotny, Jesper Petersen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 19, 2025
Prevalence of tick-borne neoehrlichia mikurensis in individuals undergoing B-cell depleting therapy in Denmark: A prospective cohort study 2023-2024Helene Mens, Rosa Gynthersen, Jeppe Romme Christensen, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Ugeskrift for Laeger|June 8, 2012
[Treatment of metformin-associated lactate acidosis by haemodialysis]Karin Schousboe, Daniel El Fassi, Erik Lilja Secher, et al.
Clinical Immunology (Orlando, Fla.)|October 31, 2008
Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodiesDaniel El Fassi, J Paul Banga, Jacqueline A Gilbert, et al.
Molecular Diagnosis & Therapy|March 9, 2021
Improved Variant Detection in Clinical Myeloid NGS Testing by Supplementing a Commercial Myeloid NGS Assay with Custom or Extended Data Filtering and Accessory Fragment AnalysisLone Schejbel, Guy Wayne Novotny, Marie Fredslund Breinholt, et al.
Rheumatology (Oxford, England)|December 23, 2023
Treatment experiences with focus on IL-6R inhibition in patients with VEXAS syndrome and a case of remission with azacytidine treatmentMorten M Johansen, Daniel El Fassi, Christoffer T H Nielsen, et al.
Ugeskrift for Laeger|January 5, 2018
[Multicentric reticulohistiocytosis is a rare form of paraneoplasia]Anna Maria Anderson, Tanja Todberg, Kristian Kofoed, et al.
Acta Ophthalmologica|September 30, 2009
Evidence of orbital B and T cell depletion after rituximab therapy in Graves' ophthalmopathyJacob F Nielsen, Daniel El Fassi, Claus H Nielsen, et al.
Ugeskrift for Laeger|February 10, 2023
Rosa Maja Møhring Gynthersen, Frederikke Christina Knudtzen, Anders Porskrog, et al.
International Journal of Laboratory Hematology|February 10, 2022
The value of next-generation sequencing in routine diagnostics and management of patients with cytopeniaMarie Fredslund Breinholt, Kåre Nielsen, Lone Schejbel, et al.
Leukemia & Lymphoma|July 2, 2019
Progression of <i>JAK2-</i>mutant polycythemia vera to <i>CALR</i>-mutant myelofibrosis severely impacts on disease phenotype and response to therapyMorten Orebo Holmström, Guy W Novotny, Jesper Petersen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 19, 2025
Prevalence of tick-borne neoehrlichia mikurensis in individuals undergoing B-cell depleting therapy in Denmark: A prospective cohort study 2023-2024Helene Mens, Rosa Gynthersen, Jeppe Romme Christensen, et al.
Pageof 5